Allianz Asset Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
+12,900
New +$839K ﹤0.01% 1830
2025
Q2
– Sell
-17,000
Closed -$667K – 2306
2025
Q1
$667K Buy
17,000
+1,000
+6% +$45K ﹤0.01% 1787
2024
Q4
$744K Hold
16,000
– – ﹤0.01% 1734
2024
Q3
$723K Hold
16,000
– – ﹤0.01% 1743
2024
Q2
$788K Buy
+16,000
New +$652K ﹤0.01% 1670
2022
Q3
– Sell
-1,560,172
Closed -$54.5M – 2129
2022
Q2
$54.5M Sell
1,560,172
-48,465
-3% -$1.72M 0.05% 374
2022
Q1
$79.4M Sell
1,608,637
-11,301
-0.7% -$626K 0.06% 336
2021
Q4
$125M Sell
1,619,938
-108,200
-6% -$11.1M 0.09% 256
2021
Q3
$185M Buy
1,728,138
+76,905
+5% +$8.81M 0.14% 151
2021
Q2
$220M Sell
1,651,233
-52,377
-3% -$6.09M 0.19% 114
2021
Q1
$211M Buy
1,703,610
+1,592,545
+1,434% +$242M 0.2% 110
2020
Q4
$15.7M Buy
111,065
+16,446
+17% +$1.82M 0.02% 695
2020
Q3
$7.19M Sell
94,619
-53,148
-36% -$3.31M 0.01% 866
2020
Q2
$6.69M Buy
147,767
+63,018
+74% +$2.26M 0.01% 1068
2020
Q1
$2.59M Buy
84,749
+18,202
+27% +$489K ﹤0.01% 1431
2019
Q4
$1.4M Buy
66,547
+16,751
+34% +$392K ﹤0.01% 2047
2019
Q3
$1.19M Buy
+49,796
New +$1.45M ﹤0.01% 2052

Other funds holding TWST

Allianz Asset Management's TWST Position: Q2 2026 in Review

Allianz Asset Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 12,900 shares worth $1.33M. The stake represents ﹤0.01% of the portfolio and ranks #1830 among its holdings. This is a return to the name: Allianz Asset Management previously reported a position in TWST as recently as Q1 2025.

Allianz Asset Management first reported a position in TWST in Q3 2019 and has held it in 17 quarters since. The position peaked at $220M in Q2 2021. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Allianz Asset Management held 12,900 shares of Twist Bioscience worth $1.33M as of Q2 2026.
  • Twist Bioscience was a new Allianz Asset Management position in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1830 holding.
  • Allianz Asset Management first reported a position in Twist Bioscience in Q3 2019 and has held it in 17 quarters since.
  • Allianz Asset Management's Twist Bioscience position peaked at $220M in Q2 2021.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.